Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer

Overview of attention for article published in Journal of Molecular Medicine, November 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 97 Dimensions

Readers on

mendeley: 78 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

Combination therapy of HSP90 inhibitors with platinum-containing agents

Grant US-10500193-B2

United States of America

Cancer therapy using a combination of HSP90 inhibitors with topoisomerase I inhibitors

Grant US-9439899-B2

United States of America

Combination therapy of HSP90 inhibitors with BRAF inhibitors

Grant US-9402831-B2

United States of America

Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor

Grant US-9205086-B2

United States of America